Navigation Links
Manhattan Research: Physician New Media Adoption in Emerging Pharma Markets - Webcast April 3
Date:3/23/2009

;    Use and impact of sales representatives for clinical and pharmaceutical information
-     Internet access, frequency, types, and activities online
-     Mobile technology adoption, including PDAs/smartphones, MP3/iPods, and SMS messaging
-     Advanced online activities such as online video, blogs, podcasting, and wikis
-     Search engine reliance and frequency
-     Interest in health email newsletters, chat groups, and disease management tools

"Physician technology adoption and integration trends in emerging pharma markets such as China and South Korea are poised to significantly impact the next generation of pharmaceutical marketing," said Meredith Abreu Ressi, Vice President Research at Manhattan Research.

Sign up for Complimentary Webinar - Friday, April 3, 2009
Taking the Pulse® Asia: Physicians and Emerging Information Technologies

Manhattan Research Vice President of Research Meredith Abreu Ressi will host the upcoming webinar, "Taking the Pulse® Asia: Physicians and Emerging Information Technologies" on Friday, April 3, 2009. Ressi will focus on the latest pharma marketing trends from Taking the Pulse® Asia, discuss why these emerging markets are critical to pharma companies, and explain how this knowledge fits into a global marketing strategy.

Key topics include physician adoption and behavior related to the Internet, Web 2.0 technologies, email communication, PDAs/smartphones, search engine reliance, tech-enabled sales reps, and electronic medical records.

Session 1: Friday, April 3, 9:00 AM EST
Session 2: Friday, April 3, 3:00 PM EST

To request an invitation to this exclusive webinar, please visit www.manhattanres
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available
2. The Massage Spot Announces Opening of Manhattan Beach Location; Seeks Investors for Growth of Affordable Luxury Mini Day Spa Concept
3. Eli Manning Leads March for Babies in Manhattan
4. 1 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9/11
5. Manhattan Scientifics Acquires Metallicum, Inc.
6. Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education
7. Eli Manning to Lead March for Babies(R) in Manhattan
8. Experimental Biology 2008 Todays Research: Tomorrows Health, April 5-9
9. New EBRI/Commonwealth Fund Research: Enrollment in Consumer-Driven Plans Remains Low, Survey Shows
10. Conning Research: Long Term Care Insurance Industry Continues to Search for Broader Market
11. New Research: Americans Underestimate Dangers of Sudden Cardiac Arrest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... The Hemophilia Federation of America (HFA) expresses its ... Teamsters Local 929 and the American Red Cross ... depends on skilled workers to provide clean, safe ... products such as clotting factor for use in ... The Division of Blood Services at the American ...
(Date:12/14/2009)... Exercise benefited men whose disease had been treated, hadn,t ... -- Exercise appears to reduce the risk of death ... study, which began in January 1986, included 668 men ... stage III colon cancer that had not spread (nonmetastatic ... that asked them about any new cancer and disease ...
(Date:12/14/2009)... study finds, , , MONDAY, Dec. 14 (HealthDay News) -- ... morning without a cup or two of java: Coffee ... type 2 diabetes. , That,s the conclusion of ... you drink, the lower your risk of diabetes. Every ... reduction in the risk of diabetes, the researchers said. ...
(Date:12/14/2009)... poorly treated and highly stigmatized, according to psychiatrists ... M.D., Ph.D. So these Washington University physicians have ... In "Demystifying Psychiatry," Zorumski and Rubin, who have ... patients and helping patient families, say some of ... result from a lack of understanding psychiatry and ...
(Date:12/14/2009)... lower rates for meth and smoking, but concerns ... (HealthDay News) -- Fewer teenagers are using methamphetamine, ... abuse of prescription drugs remains high, U.S. health ... newer drugs, such as the hallucinogenic salvia leaf ... for treatment of attention-deficit hyperactivity disorder (ADHD), appear ...
Breaking Medicine News(10 mins):Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4
... Oct. 10 A senior citizen,soared over the 13,500-foot peaks ... was taken by retired WW II B-25 pilot Roy,Heden. The ... line of Silverado Senior Living, where Heden was a patient.,Called ... cards and it has helped,many realize a special activity at ...
... careful screening for these patients, researcher says , , FRIDAY, ... syndrome have a 75 percent higher risk for developing ... suggests. , "Metabolic syndrome is a conglomeration of three ... prognosis for certain illnesses, including a number of cancers," ...
... Center (BMC) has received a $5,807,469 grant over five years ... Boston Claude D. Pepper Older Americans Independence Center. BMC,s Pepper ... country. , The Claude D. Pepper Older Americans Independence ... the late U.S. senator from Florida. During his five decades ...
... A nationally recognized faculty will,present the very ... the multimedia course "Optimizing Adjuvant Breast Cancer,Strategies: From ... Month., It is challenging for practicing oncologists ... to date on the latest patient care,advances. This ...
... a thorough review of multiple,competitive bids, the Virginia ... selected Policy Studies Inc. (PSI) to operate its,full-service ... districts.,PSI is a leading provider of health and ... at approximately $7 million annually and,will run through ...
... study says , , THURSDAY, Oct. 9 (HealthDay News) -- People ... and tolerate sorafenib drug therapy equally well, a new study ... Journal of the National Cancer Institute , counters the ... therapy and are more likely to suffer side effects than ...
Other Medicine News:Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 2Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 3Health News:Boston Medical Center receives $5.8m grant 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2Health News:PSI Selected to Operate Virginia's Child Support Program in Chesapeake and Hampton 2
(Date:12/14/2009)... Tenn., Dec. 14 Embarrassing and sometimes uncomfortable ... National researchers are taking note of a new ... approval process. The Knoxville-based company, EDP Biotech ... revolutionary, ColoMarker, an affordable medical device doctors can use ... sample. "When you consider that 30% of colon ...
(Date:12/14/2009)... Calif., Dec. 14 Alexza Pharmaceuticals, Inc. (Nasdaq: ... its New Drug Application (NDA) for Staccato® loxapine (AZ-004) ... AZ-004 is an inhalation product candidate being developed for ... or bipolar disorder. The IND for Staccato ... 2005. ,, "AZ-004 has delivered a predictable and consistent ...
(Date:12/14/2009)... 14 Corgenix Medical Corporation (OTC ... marketer of diagnostic test kits, and BG ... sciences company, announced today a supply agreement ... products in enzyme-linked immunosorbent assay (ELISA) microtiter ... is seeking regulatory clearance in the United ...
Breaking Medicine Technology:EDP Biotech Takes Next Step in the Development of ColoMarker 2EDP Biotech Takes Next Step in the Development of ColoMarker 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Drug ads ineffective for boosting sales could cost taxpayers 3A UBC Harvard study 61994 1Drug ads ineffective for boosting sales could cost taxpayers 3A UBC Harvard study 61994 2The cause behind the characteristic shape of a long leaf revealed 10881 1The cause behind the characteristic shape of a long leaf revealed 10881 2Water droplets direct self assembly process in thin film materials 14949 1Water droplets direct self assembly process in thin film materials 14949 2
... SAN FRANCISCO, Oct. 26 Semafore Pharmaceuticals Inc.,announced ... at the 2007,AACR-NCI- EORTC International Conference in San ... synergistic effects,with certain standard chemotherapy agents in vitro ... showed significant (p<0.001) synergistic growth,inhibition of prostate cancer ...
... 25 Paratek Pharmaceuticals, Inc. announced,today that ... a $40 million private,financing. Aisling Capital led ... D.E. Shaw and Boston Life Science Venture ... BioVentures, BioFund,Ventures, HBM BioVentures, Lombard Odier Darier ...
Other Medicine Technology:Semafore's PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents 2Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections 2Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections 3Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections 4
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: